Moleculin Biotech Stock (NASDAQ: MBRX) stock price, news, charts, stock research, profile.
Open | $5.580 |
Close | $5.910 |
Volume / Avg. | 78.010K / 30.764K |
Day Range | 5.179 - 6.235 |
52 Wk Range | 4.340 - 24.750 |
Market Cap | $12.719M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 37 |
Short Interest | 1.46% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Moleculin Biotech (NASDAQ: MBRX) through any online brokerage.
Other companies in Moleculin Biotech’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Virios Therapeutics (NASDAQ:VIRI), Dominari Holdings (NASDAQ:DOMH), Imunon (NASDAQ:IMNN) and T2 Biosystems (NASDAQ:TTOO).
The latest price target for Moleculin Biotech (NASDAQ: MBRX) was reported by Maxim Group on Tuesday, March 26, 2024. The analyst firm set a price target for 20.00 expecting MBRX to rise to within 12 months (a possible 250.26% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Moleculin Biotech (NASDAQ: MBRX) is $5.71 last updated March 28, 2024 at 5:57 PM EDT.
There are no upcoming dividends for Moleculin Biotech.
Moleculin Biotech does not have any upcoming earnings scheduled.
There is no upcoming split for Moleculin Biotech.
Moleculin Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.